Pavel Alexyuk (P G Alexyuk)

Scopus Author ID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Angiotensin Converting Enzyme

Molecular Dynamics Simulations

Top Venues

Molecules (Basel, Switzerland)

Archives of virology

This page only lists publications with an associated author ORCID identifier.

Publications

Pavel Alexyuk, Andrey Bogoyavlenskiy, Madina Alexyuk, Kuralay Akanova, Yergali Moldakhanov, Vladimir Berezin
Isolation and Characterization of Jumbo Coliphage vB_EcoM_Lh1B as a Promising Therapeutic Agent against Chicken Colibacillosis. Microorganisms 11 (6) (2023)
Andrey Bogoyavlenskiy, Madina Alexyuk, Pavel Alexyuk, Vladimir Berezin, Faisal A Almalki, Taibi Ben Hadda, Alaa M Alqahtani, Saleh A Ahmed, Abdolmajid Fata, Joazaizulfazli Jamalis
Computer Analysis of the Inhibition of ACE2 by Flavonoids and Identification of Their Potential Antiviral Pharmacophore Site. Molecules (Basel, Switzerland) 28 (9) (2023)
Pavel Alexyuk, Andrey Bogoyavlenskiy, Madina Alexyuk, Kuralay Akanova, Yergali Moldakhanov, Vladimir Berezin
Isolation and Characterization of Jumbo Coliphage vB_EcoM_Lh1B as a Promising Therapeutic Agent against Chicken Colibacillosis. Microorganisms 11 (6) (2023)
Andrey Bogoyavlenskiy, Madina Alexyuk, Pavel Alexyuk, Vladimir Berezin, Faisal A Almalki, Taibi Ben Hadda, Alaa M Alqahtani, Saleh A Ahmed, Abdolmajid Fata, Joazaizulfazli Jamalis
Computer Analysis of the Inhibition of ACE2 by Flavonoids and Identification of Their Potential Antiviral Pharmacophore Site. Molecules (Basel, Switzerland) 28 (9) (2023)
Pavel Alexyuk, Andrey Bogoyavlenskiy, Madina Alexyuk, Kuralay Akanova, Yergali Moldakhanov, Vladimir Berezin
Isolation and Characterization of Lytic Bacteriophages Active against Clinical Strains of E. coli and Development of a Phage Antimicrobial Cocktail. Viruses 14 (11) (2022)
Pavel Alexyuk, A P Bogoyavlenskiy, M S Alexyuk, A S Turmagambetova, I A Zaitseva, E S Omirtaeva, V E Berezin
Adjuvant activity of multimolecular complexes based on Glycyrrhiza glabra saponins, lipids, and influenza virus glycoproteins. Archives of virology 164 (7) (2019)